Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting By: MarketWatch May 27, 2022 at 09:57 AM EDT This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks. Read More >> Related Stocks: 4D Molecular Therapeutics Inc Amgen Arcellx, Inc. - Common Stock Gsk Plc ADR Iovance Biotherapeutics Inc Mirati Therapeutics S&P Biotech SPDR Springworks Therapeutics Inc Zymeworks Inc
